Pharma Reviews: Indian pharma revenue growth to cool off in next 3 years: ICRA

In spite of these ongoing challenges, the ICRA report says several Indian pharma companies have ramped up their R&D spend, targeting pipeline of ...
Read more: Indian pharma revenue growth to cool off in next 3 years: ICRA